Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
23.12
0.00 (0.00%)
Sep 10, 2025, 4:00 PM - Market open
THNR Holdings Information
THNR is an equity ETF with a total of 24 individual holdings. The top holdings are Eli Lilly and Company stock at 11.68%, Novo Nordisk at 8.59%, Regeneron Pharmaceuticals at 7.30%, Amgen at 6.44%, and Chugai Pharmaceutical at 5.90%.
Total Holdings
24
Top 10 Percentage
66.97%
Asset Class
Equity
ETF Category
Health
Assets
4.23M
PE Ratio
17.71
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 11.68% |
| 2 | NVO | Novo Nordisk A/S | 8.59% |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 7.30% |
| 4 | AMGN | Amgen Inc. | 6.44% |
| 5 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 5.90% |
| 6 | ABBV | AbbVie Inc. | 5.59% |
| 7 | AZN | AstraZeneca PLC | 5.58% |
| 8 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 5.32% |
| 9 | GILD | Gilead Sciences, Inc. | 5.30% |
| 10 | MRK | Merck & Co., Inc. | 5.27% |
| 11 | HKG: 1801 | Innovent Biologics, Inc. | 5.20% |
| 12 | SWX: ROG | Roche Holding AG | 5.20% |
| 13 | PFE | Pfizer Inc. | 5.07% |
| 14 | TYO: 4507 | Shionogi & Co., Ltd. | 4.46% |
| 15 | HIMS | Hims & Hers Health, Inc. | 3.60% |
| 16 | CPH: ZEAL | Zealand Pharma A/S | 2.87% |
| 17 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.96% |
| 18 | VKTX | Viking Therapeutics, Inc. | 1.79% |
| 19 | HKG: 3933 | The United Laboratories International Holdings Limited | 1.40% |
| 20 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 0.88% |
| 21 | AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | 0.47% |
| 22 | n/a | DEPOSITS WITH BROKER FOR SHORT POSITIONS | 0.11% |
| 23 | n/a | US DOLLARS | 0.03% |
| 24 | n/a | SOUTH KOREA WON | 0.00% |
As of Sep 8, 2025